Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341

Oncology (Williston Park). 2000 Nov;14(11):1589-90, 1593-4, 1597.
No abstract available

Publication types

  • Directory

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / adverse effects
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Clinical Trials, Phase I as Topic*
  • Clinical Trials, Phase II as Topic*
  • Hematologic Neoplasms / drug therapy
  • Humans
  • Neoplasms / drug therapy
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / therapeutic use*
  • Pyrazines / adverse effects
  • Pyrazines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib